Omkar Speciality Chemicals acquires LASA Laboratory Media Coverage of our company in The India Infoline (12/04/2012)
Located at Mahad in Raigad district, south west of Maharashtra has been an established player in the anthelmintic / veterinary API segment with state-of-the-art API manufacturing facility.
Omkar Speciality Chemicals Limited, one of the leading manufacturers of speciality chemicals, such as selenium derivatives, iodine derivatives, molybdenum derivatives, cobalt bismuth derivatives and pharma intermediates for life saving drugs has recently forayed into pharmaceutical business with its recent acquisition of LASA Laboratory Private Limited.
Located at Mahad in Raigad district, south west of Maharashtra has been an established player in the anthelmintic / veterinary API segment with state-of-the-art API manufacturing facility.
Talking to the media, Pravin S. Herlekar, Chairman & Managing Director, Omkar Speciality Chemicals Limited (OSCL) said, "There is a colossal demand in the API manufacturing space, and with Indian drug manufacturing sector gaining international prominence, the acquisition of LASA Laboratory was the right move for our group to venture into the pharma business. It is also a part of our group's forward integration strategy "
"The acquisition will enable us to focus on manufacturing Anthelmintics, such as Albendazole EP, Albendazole IP/USP, Cyromazine, Fenbendazole BP VET/ EP, Nitroxynil BP Vet, Ricobendazole, Toldimphos Sodium and Triclabendazole," informed Herlekar.
"Our new API division is already in operations and will initially focus on continuing the existing API business of LASA Laboratory, which has massive demand in India and abroad. The products are used as Anthelmintics or deworming agents for veterinary," informed Mr. Herlekar.
"Currently, our product portfolio comprises 10 products in the Veterinary Anthelmentics segment, mainly Benzimidazoles and other active pharma ingredients," he added.